A major mechanism for regulating protein function in eukaryotes involves the covalent attachment of ubiquitin or ubiquitin-like proteins (referred to collectively as UBLs) through an isopeptide bond to the primary amino group of a target, often from a Lys side chain. Posttranslational modification by UBLs regulates numerous processes, including cell division, immune responses and embryonic development. Accordingly, defects in UBL pathways are associated with various diseases, particularly cancer, neurodegenerative disorders, and muscle atrophy or cachexia 1, 2 . The UBL carboxyl termini are attached to other proteins or, in some cases, lipids, generally through E1-E2-E3 multienzyme cascades (FIG. 1a) . At the start of each UBL cascade is an E1 (or activating) enzyme, which activates the UBL and then directs the UBL to downstream pathways (FIG. 1) . The ubiquitin system itself is the best-understood UBL pathway. In the first step of ubiquitin activation, the E1 enzyme binds ATP•Mg 2+ and ubiquitin, and catalyses ubiquitin C-terminal acyl-adenylation. In the second step, the catalytic Cys in the E1 attacks the ubiquitin~adenylate to form the activated ubiquitin~E1 thioester-bonded complex (the tilde (~) represents a highenergy bond between the C terminus of the UBL and AMP or the conjugation machinery, whereas an en rule (-) represents a non-covalent complex). Eventually, an E1 engages one of many cognate E2 conjugating enzymes (hereafter referred to as E2s) to initiate downstream signalling, typically through the coordinated function of E3 ubiquitin ligases (hereafter referred to as E3s) (FIG. 1) .
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E3s contain binding sites for both charged E2s and ubiquitylation substrates 3 . For the largest class of E3s (the RING and RING-related U-box family), an ε-amino group of a Lys residue in the associated substrate attacks the thioester of the transiently associated charged E2, making an isopeptide bond with ubiquitin. The discharged E2 then dissociates from the E3, allowing a second charged E2 to interact with the E3 to facilitate a second round of ubiquitin transfer, either by attack of a Lys residue in ubiquitin itself or by attack of a different Lys in the substrate. Multiple E2 cycles of E1-mediated ubiquitin loading and subsequent unloading -through a range of mechanisms (reviewed in ReF. 4) -lead to polyubiquitylation of the substrate (FIG. 1a,b) .
Substrates with four or more linked ubiquitins are often targeted to the 26S proteasome for degradation. However, ubiquitin itself can have many functions, depending, at least in part, on how it is attached to targets. In addition to polyubiquitin chains directing targets to proteasome-dependent degradation, monoubiquitin or polyubiquitin chains linked through a range of Lys residues in the ubiquitin molecule can alter the localization or activity of the target protein, generally through recruitment of ubiquitin-binding proteins [5] [6] [7] [8] [9] . In total, 17 human UBLs from 9 phylogenetic classes have been reported to be conjugated to other molecules 1, [10] [11] [12] [13] [14] [15] [16] [17] (FIG. 1c) . All UBLs have a common overall fold but, in general, the different UBLs have their own discrete E1-E2-E3 cascades and have distinct effects on Nature Reviews | Molecular Cell Biology The E1 enzyme ubiquitin-activating enzyme 1 (UBA1) reacts with ubiquitin to form a ubiquitin~adenylate intermediate (the tilde (~) represents a high-energy bond between the carboxy-terminal carboxylate of the ubiquitin and AMP). Ubiquitin is transferred to a Cys in the catalytic domain of UBA1 to form the activated ubiquitin~UBA1 complex. A second molecule of ubiquitin binds to the adenylation domain and is converted to ubiquitin~adenylate. The doubly loaded E1 complex is then recognized by a cognate E2 ubiquitin-conjugating enzyme, which receives ubiquitin to form a ubiquitin-charged E2. E2 enzymes recognize E3 enzymes that are associated with substrates and transfer ubiquitin to the substrate. Multiple cycles of binding to charged E2 enzymes leads to the formation of ubiquitin chains, which are recognized by the 26S proteasome, facilitating substrate degradation. b | Enzymatic mechanism of the ubiquitin activation and conjugation cycle. For ubiquitin, the E1 enzyme is UBA1. Ub(A) represents ubiquitin that is associated non-covalently at the adenylation active site, and Ub(T) represents ubiquitin that is covalently linked to the catalytic Cys of UBA1 through a thioester bond.
Step 1 shows adenylate formation, step 2 shows thioester formation, step 3 shows double ubiquitin loading of E1 and step 4 shows ubiquitin transfer to E2.
Step 2 is repeated on the E1 Ub(A)~adenylate generated in step 4 to continue the cycle. c | The pathways that use the 17 ubiquitin-like proteins (UBLs; yellow) that are known to be conjugated to other molecules through their C-terminal Gly residue are arranged around the phylogenetic tree. E1 enzymes (purple) for specific UBLs can be monomeric (UBA1, UBA6 (also known as UBE1L2) and UBE1L (also known as UBA7), heterodimeric (SAE1-UBA2 and NAE1-UBA3), or homodimeric (UBA4, ATG7 and probably UBA5) (ATG7 is autophagy-related protein 7, NAE1 is neuronal precursor cell-expressed developmentally downregulated protein 8 (NEDD8)-activating enzyme 1 and SAE1 is small ubiquitin-related modifier (SUMO)-activating enzyme 1). E2 enzymes (green) associate with E1 proteins and receive the activated UBL through a trans-thioesterification reaction. E2s then transfer their UBLs to substrates (orange), typically through association with an E3 ubiquitin ligase (magenta). Ahp1, alkyl hydroperoxide reductase 1; GABARAPL, gamma-aminobutyric acid receptor-associated protein-like; ISG15, interferon-stimulated gene 15; MAP1LC3, microtubuleassociated protein 1 light chain 3; RBX1, RING-box protein 1; UBC, UBL-conjugating enzyme; UFC1, UFM1-conjugating enzyme 1; UFM1, ubiquitin-fold modifier 1; URM1, ubiquitin-related modifier 1.
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Thioester bond
Covalent linkage of a sulphur with an acyl group. In the case of ubiquitin-like protein (UBL) cascades, the Cys sulphur of an enzyme is linked to the terminal carbon of a UBL.
26S proteasome
A large multisubunit protease complex that selectively degrades polyubiquitylated proteins. It contains a 20S particle that carries the catalytic activity and two regulatory 19S particles.
their targets 12, 13, 18 . Besides ubiquitin, other well-studied UBLs are neuronal precursor cell-expressed developmentally downregulated protein 8 (NEDD8) and small ubiquitin-related modifier (SuMo) family members, both of which are essential for viability in many eukaryotes. NEDD8 conjugation is initiated by its dedicated E1, the heterodimeric NAE1-UBA3 (NEDD8-activating enzyme 1-ubiquitin-activating enzyme 3) complex. Attachment of NEDD8 to its predominant target, the cullins, enhances the enzymatic activity of cullin-RING E3 ubiquitin ligases [19] [20] [21] [22] (FIG. 1c) . By contrast, three human SuMos (SuMo1, SuMo2 and SuMo3) are conjugated to many diverse proteins. All three are activated by a common E1, the heterodimeric SuMo-activating enzyme 1 (SAE1)-UBA2 complex (FIG. 1c) . SuMo attachment often alters the interaction of a target with other proteins through interactions between SuMo and SuMo-binding motifs 23 .
A number of other UBLs function in diverse biological pathways (FIG. 1c) . The conjugation of two UBLsinterferon-stimulated gene 15 (ISG15) and FAT10 -are under the control of the interferon system, which responds to viral signals. ISG15, which is the product of an interferon-inducible gene, is activated by the E1 UBA7 (FIG. 1c) and is transferred to many targets in a wide range of pathways through a specific E2, UBL-conjugating enzyme 8 (UBCH8; also known as UBE2L6). The expression of UBCH8 is also under interferon control (FIG. 1c) . Additional UBLs, including the autophagy-related protein 8 (ATG8) and ATG12 families, ubiquitin-fold modifier 1 (uFM1) and ubiquitin-related modifier 1 (uRM1), are activated by their own E1 enzymes (ATG7, UBA5 and UBA4 (MoCS3 in humans), respectively) (FIG. 1c) . ATG8 and ATG12 are involved in multiple steps in autophagy, a process by which cells degrade their cytoplasmic organelles through the lysosome (see below). By contrast, uRM1 is functionally distinct in that it is used in biosynthetic reactions that involve sulphur transfer.
This Review summarizes our current understanding of the mechanisms by which E1 enzymes (hereafter referred to as E1s) initiate UBL conjugation.
Prokaryotic antecedents of E1s and UBLs
UBLs and E1s have their origins in prokaryotic biosynthetic pathways. The bacterial proteins molybdopterinconverting factor subunit 1 (MoaD) and thiamine biosynthesis protein S (ThiS), which share the UBL fold 24, 25 ( FIG. 2a) , carry sulphur for incorporation into molybdopterin and thiazole, respectively. Molybdopterin is a small molecule cofactor that is found in proteins that bind to molybdenum, whereas thiazole is a precursor in the production of thiamine. Furthermore, in a reaction that resembles that catalysed by eukaryotic E1s, MoaD and ThiS are activated by C-terminal acyl-adenylation by the bacterial enzymes molybdopterin biosynthetic enzyme B (MoeB) and ThiF, respectively 26, 27 . MoeB and ThiF share sequence homology with the domain of eukaryotic E1s that is responsible for UBL binding and adenylation, and is the common building block for all E1s (FIG. 3) . Thus, MoeB and ThiF embody minimal modules that contain UBL-E1 recognition and adenylation activities 12, 13 . The crystal structures of MoeB-MoaD, MoeBMoaD-ATP, MoeB-MoaD~adenylate, ThiF-ATP and ThiF-ThiS complexes have provided key insights into the mechanism of UBL recognition and activation 25, 28, 29 . The MoeB and ThiF structures are homodimeric (FIGS 2a, 3a) and have two symmetric catalytic centres (FIG. 2) . Each contains a four-stranded β-sheet that binds to a MoaD or ThiS hydrophobic surface corresponding to the essential Leu8-Ile44-His68-val70 hydrophobic patch of ubiquitin 30 . This uBL-binding site of MoaD or ThiS is structurally stabilized by homodimerization of MoeB or ThiF (FIG. 2) . The C-terminal tail of MoaD or ThiS extends towards the ATP. A conserved ATPbinding Arg finger comes from the opposite MoeB or ThiF monomer to that containing the nucleotidebinding site in the complex, and a conserved Asp coordinates Mg 2+ . In turn, this alleviates electrostatic repulsion is not a UBL but is instead a heptapeptide with an atypical C-terminal sequence 31 . Conversely, the small prokaryotic UBL Pup from Mycobacterium tuberculosis becomes conjugated to 26S proteasome targets 32 . However, to date, no MoeB or ThiF homologue has been identified in this pathway. Thus, it seems likely that a range of unexpected variations on UBL activation mechanisms will be discovered in prokaryotes.
Diversity and specificity of E1s
In humans, there are eight E1s that are known to initiate UBL conjugation [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] (FIGS 1,3). Each of these E1s is nucleated by a homodimeric or heterodimeric adenylation domain, which is responsible for initial UBL recognition and acyl-adenylation. This adenylation domain resembles MoeB and ThiF 48 (FIG. 3) . In addition to their common adenylation domain, E1s also have a range of other domains. For clarity, we refer to the E1s for ubiquitin (UBA1 and UBA6 (also known as uBE1L2)), SuMo (SAE1-uBA2), NEDD8 (NAE1-UBA3) and ISG15 (UBA7) as canonical, owing to their related domain structures and enzymatic mechanisms. Canonical E1s have two MoeB-and ThiF-homologous repeats, either in a single polypeptide or two subunits that correspond to the amino-and C-terminal halves of homomeric E1s 12, 13, 48 (FIG. 3A) . The adenylation domains of canonical E1s are pseudosymmetrical: one MoeB or ThiF repeat binds to ATP•Mg 2+ and UBL, and the other primarily provides structural stability [49] [50] [51] (FIG. 3) .
Canonical E1s also share two additional domains for UBL transfer to E2s (see below). we refer to E1s for uRM1 (uBA4), uFM1 (uBA5) and the ATG12 and ATG8 families (ATG7) as 'non-canonical' . Evidence indicates that non-canonical E1s contain homodimeric adenylation domains (FIG. 3Bb) , which presumably adopt symmetrical structures like MoeB and ThiF 43, [52] [53] [54] . Each of these E1s also has unique sequences (FIG. 3A) .
Despite overall related architectures, several UBL pathways display their own idiosyncrasies (FIG. 1) . we describe specialized features of the ubiquitin, SuMo and autophagy pathways as examples. In vertebrates and sea urchins, two different E1s initiate the conjugation of ubiquitin [44] [45] [46] , despite prior notions that each E1 activates at least one unique UBL. Indeed, for more than two decades, the central dogma in the field was that a single ubiquitin-activating enzyme, UBA1, charges E2s that are dedicated to the ubiquitin system, as in lower eukaryotes. However, recent studies that identified UBA6 as a second E1 enzyme for ubiquitin have challenged this dogma [44] [45] [46] . UBA1 and UBA6 are distantly related (they are ~40% identical); in fact, UBA1 is phylogenetically more closely related to UBA7 (the E1 for ISG15) 44 . Nevertheless, UBA6 is charged by ubiquitin in vitro and in cells. Furthermore, UBA6 is uniquely responsible for transferring ubiquitin to USE1, a UBA6-specific E2 (ReF. 44) . UBA6 and USE1 are found from humans to zebrafish, as well as sea urchin, and are ubiquitously expressed, but they are absent from worms, flies and yeast, which indicates a selective role in certain multicellular organisms. For example, deletion of the mouse Uba6 gene results in embryonic lethality 46 . Intriguingly, at high protein concentrations, UBA6 can form a complex with the UBL FAT10 in vitro 46 , and depletion of UBA6 can block the conjugation of FAT10 to unknown proteins. However, mice that lack FAT10 are viable, suggesting that the essential functions of UBA6 are not linked to FAT10 activation.
The SuMo pathway has an opposite, perplexing feature -the only E1 in higher eukaryotes (the SAE1-UBA2 heterodimer) 38, 39 activates at least three SuMos. Similarly, the only E1 that is involved in autophagy, ATG7, activates multiple structurally distinct UBL proteins -Atg8 and Atg12 in budding yeast and further ATG8 relatives in higher eukaryotes 47, 55 (FIG. 1) . Thus, how E1s recognize their distinct UBLs, and when and why different E1s activate ubiquitin, are important questions.
Catalytic mechanisms of canonical E1s
The catalytic mechanism is best characterized for the ubiquitin E1 UBA1 (FIG. 1b) . After UBL C-terminal adenyl ation 56-58 , the ubiquitin~adenylate is attacked by the catalytic Cys of UBA1, producing a covalent thioester linkage between the Cys sulphydryl of UBA1 and the C terminus of ubiquitin 56,57,59,60 . Subsequently, UBA1 catalyses the adenylation of a second ubiquitin molecule 56, 57 . Thus, UBA1 becomes asymmetrically loaded with two ubiquitin molecules at distinct active sites: one ubiquitin molecule is covalently linked to the catalytic Cys of the E1 enzyme through a thioester bond; and a second ubiquitin is associated non-covalently at the adenylation active site. These ubiquitin molecules are hereafter referred to as ubiquitin(T) and ubiquitin(A), respectively -this notation also applies throughout the article for the other UBLs. Ultimately, UBA1 physically associates with a cognate E2 conjugating enzyme and a thioester transfer reaction ensues, whereby the C terminus of ubiquitin(T) is transferred to the catalytic Cys of the E2 enzyme 3, 57, [61] [62] [63] . Individual steps of the E1 reaction are reversible. Progression of the cascade is driven by the release of the small molecule products inorganic phosphate and AMP in the first and second steps, respectively [56] [57] [58] 62, 63 . A curious feature of the E1-E2 cycle is the asymmetric double loading of E1 with two ubiquitin molecules 56, 57 . why does this double loading occur? Although a previous study showed that a partially purified UBA1~ubiquitin complex containing only the single ubiquitin(T) is capable of transferring the ubiquitin to an E2, this transfer is accelerated by ubiquitin(A)~adenylate or ATP•Mg 2+ (ReF. 64). Also, UBA1 adenylation active site mutants generate an E2~ubiquitin complex more efficiently than would be predicted based on their crippled adenylation of ubiquitin, which further indicates that there is crosstalk between the adenylation active site and E1-E2 thioester transfer 65 . Coupling the second adenylation reaction with ubiquitin transfer to E2 might make the cascade energetically or conformationally favourable, or might prevent the E1 from becoming trapped in an unfavourable conformation (FIG. 1b) .
A mechanism that is similar to that of UBA1 has been confirmed for the heterodimeric E1 of NEDD8, NAE1-UBA3, through biochemical and structural studies [66] [67] [68] . Furthermore, most of the features of this scheme (including adenylation, E1~UBL thioester intermediates and E2 charging) have also been observed for SAE1-UBA2, UBA6 and UBA7, and the similarities of their amino acid sequences (and, where determined, their tertiary structures) are also in keeping with the idea of parallel reaction mechanisms 40, 41, 44, 50, 51, 69 . Thus, it is likely that mechanistic and structural studies of a subset of canonical E1s will provide broad insights into this E1 class as a whole.
Structural insights into canonical E1s
Structural studies of human NAE1-UBA3, SAE1-UBA2, and Saccharomyces cerevisiae Uba1 alone or in complexes with ATP, UBLs and/or cognate E2s, have provided many insights into the general features of canonical Nature Reviews | Molecular Cell Biology
Ub ( E1s as well as features that are unique to the different pathways [49] [50] [51] 67, 68, [70] [71] [72] . Briefly, the structures all display an adenylation domain that resembles MoeB and ThiF, and two domains that are specific to canonical E1s: a catalytic Cys domain that contains the Cys residue involved in the E1~UBL thioester linkage, and a C-terminal ubiquitin fold domain (UFD) that binds a cognate E2 (FIG. 3A) .
The canonical E1 adenylation domain. within the E1s for ubiquitin, SuMo and NEDD8, a single adenylation active site is focused around the C-terminal repeats, similar to those found in MoeB and ThiF, in yeast Uba1 and human UBA2 and UBA3, respectively. Structural superposition of E1 adenylation domains shows extensive similarity to MoeB and ThiF, and their interactions with ATP and UBLs (FIG. 3) . Mutational analyses agree with the idea of E1-catalysed UBL acyladenylation through mechanisms that are similar to that proposed for MoeB 25, 49, 50, 65 .
A catalytic Cys domain. After the adenylation reaction, the catalytic Cys sulphydryl of the E1 enzyme attacks the UBL~adenylate, resulting in an E1~UBL(T) complex that is covalently linked by a thioester bond between the C terminus of UBL and the catalytic Cys of E1. In the structures with NEDD8, SuMo1 or ubiquitin at the uBL(A) site, a ~35 Å gap between the C terminus of UBL(A) and the catalytic Cys of E1 raises questions about UBL and E1 conformations during the formation of the thioester intermediate 50,51,67 (FIG. 3Bb) . Part of the gap might be closed if the C-terminal tail of the UBL were freed from interaction with E1 after the adenylation reaction. However, several pieces of data suggest that the E1 might adopt unknown conformations for the catalytic Cys attack of uBL~adenylate. First, ubiquitin~AMP binds uBA1 with higher affinity than free ubiquitin. UBA1 seems to contain a single nucleotide-binding site, and a non-hydrolysable analogue of ubiquitin~adenylate is a potent UBA1 inhibitor, in part by competing with ATP binding [56] [57] [58] 73 . Second, following the adenylation reaction, the Cys of UBA1 can form a thioester complex with a fluorescently labelled peptide that corresponds to the C terminus of ubiquitin 74 . Third, the UBA1 catalytic Cys domain is structurally similar in isolation and in the context of full-length UBA1 (ReFS 51,75), and domain rotation is consistent with subtle conformational differences between UBL-free and UBL(A)-bound structures 50, 67 . Insights into the thioester intermediate come from the crystal structure of a trapped E2-bound and doubly UBL-loaded NEDD8 E1 complex (FIG. 1b) , in which NEDD8(T) is covalently bound at the Cys of UBA3 through a thioester bond and NEDD8(A) is non-covalently associated at the adenylation active site 68 . Here, the catalytic Cys is in the same relative location as in free and UBL(A)-bound E1 structures (FIG. 4) . Thus, if the catalytic Cys domain undergoes conformational changes while attacking the UBL(A) C terminus, it can apparently subsequently return to a central orientation after forming the thioester bond. Although no structure has identified a general base poised to deprotonate the catalytic Cys of E1, an important role for a network of polar and charged side chains surrounding the thioester bond has been revealed by mutational analysis 68 .
The E2-binding UFD. The UFD binds to the E2 enzyme [49] [50] [51] 71 . Structural studies for the NEDD8 pathway reveal the binding of the concave β-sheet of the UFD of UBA3 to the N-terminal helix and β1-β2 loop of the core domain of UBC12, the E2 of NEDD8 (ReF. 71) (FIG. 4A) . Mutational analysis indicates that other canonical E1s bind their E2s in a similar way 44, 50, 51, [76] [77] [78] . Docking the isolated structure of the E2 bound to the UFD of the E1 on to the UFD of full-length NAE1-UBA3, SAE1-UBA2 or yeast Uba1 does not provide a model for UBL transfer from E1 to E2. In the models, the distances between Cys residues on E1 and E2 are ~30-65 Å 49, 50, 67, 71, 79 ( FIG. 4B) , whereas these residues must be juxtaposed during UBL transfer. A striking ~110° rotation of the UFD of UBA3 was observed by comparing different NEDD8 E1 structures 68 (FIG. 4Bc,C) . This difference revealed the propensity for the UFD to undergo dramatic rotation and (UBA3 is ubiquitin-activating enzyme 3, NEDD8 is neuronal precursor cell-expressed developmentally downregulated protein 8 and UBC12 is UBL-conjugating enzyme 12). The sulphydryl of the catalytic Cys in UBC12 is shown as a green sphere. B | Models of E2 enzymes (cyan) bound to the structures of complexes of an E1 enzyme and a ubiquitin-like protein (UBL) that is non-covalently associated with the E1 at the adenylation active site (hereafter referred to as UBL(A)). Arrows highlight E1 to E2 distances between Cys residues. Ba | The E1 of small ubiquitin-related modifier 1 (SUMO1), SUMO-activating enzyme 1 (SAE1)-UBA2 (PDB code 1Y8R) 50 , and the E2 of SUMO, UBC9 (PDB code 1U9B) 119 . Bb | The yeast ubiquitin E1 Uba1 (PDB code 3CMM) 51 and a ubiquitin E2 (PDB code 2AYZ) 120 . Bc | The E1 of NEDD8, NEDD8-activating enzyme 1 (NAE1)-UBA3 (PDB code 1R4M) 67 and the E2 of NEDD8, UBC12 (PDB code 1Y8X) 71 . c | A UFD rotation revealed from the structure of an E1 enzyme (NAE1-UBA3) that is bound to two UBLs -NEDD8(A) (yellow) and NEDD8 that is covalently associated with the E1 through a thioester bond (NEDD8(T); orange) -a catalytically inactive mutant E2 enzyme (UBC12) and ATP•Mg 2+ (PDB code 2NVU) 68 . E1-UBL structures are orientated and coloured as in FIG. 3 , and E1 and E2 catalytic Cys residues are shown in green. , the corresponding UBA1 surface faces towards the Cys of UBA1 (ReF. 51). Although future studies will be required to understand when and how the UFD adopts different orientations, it is possible that conformational differences among the E1s might reflect structural differences in their cognate E2 enzymes that might limit orientations for approaching UBL(T).
The UFD rotation also unmasks an additional E2-binding surface in the adenylation domain of E1, adjacent to the adenine moiety of ATP 68 . It is tempting to speculate that E2 binding adjacent to the nucleotidebinding site could have a role in coupling the adenylation and thioester transfer reactions 64, 65 .
A thioester switch directs E1 cycling Several studies have indicated that covalent thioester UBL linkage alters E1-E2 non-covalent interaction properties (FIGS 4, 5) . First, UBA1 and the E2s for ubiquitin display different relative affinities for each other in their free states and when ubiquitin is linked by a thioester bond. Free UBA1 separates from E2s during gel filtration, suggesting a low affinity 3, 61 . By contrast, UBA1 that is doubly loaded with ubiquitin binds to uncharged E2 substrates with nanomolar affinities 63 . After charging, a thioester-linked E2~UBL product is apparently released from E1, as E1 undergoes multiple reaction cycles in the presence of excess E2. Second, different affinities for free and UBL-bound enzymes might promote progression through E1-E2-E3 cascades. E1-E2 and E2-E3 interactions are mutually exclusive, owing to structural overlap between E1-and E3-binding sites on E2 molecules 71, 77, 80, 81 . Thus, the E2~UBL product would need to be released from E1 before binding to E3. Third, striking differences in E1 conformation and concomitant unmasking of cryptic E2-binding sites are observed when crystal structures of the NEDD8 E1 with and without NEDD8(T) are compared (FIG. 1b) .
Taken together, the available data suggest that canonical E1 reaction cycles might be driven by 'thioester switch' mechanisms that toggle E1-E2 affinities 63,68 (FIG. 5) . when an E1 is doubly loaded with UBLs and thioester-linked to a UBL(T), its affinity for an E2 is increased owing to additional binding sites, including the UBL(T) itself. Transfer of the covalent linkage of UBL to the catalytic Cys of E2 generates the E2~UBL thioester product. At this point, the UBL(T) is no longer covalently tethered to the E1. This eliminates one E2-binding site on E1, which might facilitate release of the product. Different E1 characteristics raise the possibility that distinct E1-E2 pathways use diverse thioesterswitching mechanisms 50,51,67 . First, the single UBA1 charges numerous ubiquitin E2 enzymes, whereas the . This causes two cryptic E2-binding sites to be unmasked, facilitating the doubly UBL-loaded E1 binding to or positioning E2 for the UBL transfer reaction. d | Following UBL transfer to the catalytic Cys of E2, the covalent tether of UBL(T) to E1 is eliminated. e | Steric clashing between E1 and E2~UBL might further facilitate the release of this product and reset the E1 for another activation cycle. The first UBL to enter the cascade is coloured in orange, and the second in yellow.
NEDD8 and SuMo pathways are restricted to selected E2 enzymes 36, 37, 61, 82 . Second, whereas free UBA1 displays low affinity for E2s, uncharged NAE1-UBA3 and SAE1-UBA2 (and their isolated UFDs) can bind their E2s 49, 50, 77, 83 . Thus, NEDD8 and SuMo E1s might require additional mechanisms to ensure the release of the E2~UBL product and to ensure E1 recycling. Accordingly, different UFD orientations in the E1-UBL(A) structures might reflect distinct thioester switches. In the UBA1-ubiquitin crystal structure, the UFD is orientated such that an associated E2 would face the catalytic Cys of UBA1. Formation of the UBA1~ubiquitin thioester complex might primarily drive E2 binding by increasing affinity through noncovalent interactions that are mediated by the thioesterbound ubiquitin. By contrast, the higher basal E1-E2 affinities in the NEDD8 and SuMo pathways might suggest that a primary role of the thioester switch might be to promote the release of the E2~UBL thioester product. In these cases, after the formation of the E2~UBL product, the rotation of the UFD into the orientation observed in NAE1-uBA3-NEDD8(A) and SAE1-uBA2-SuMo(A) structures might facilitate the release of the product owing to a clash between the E1 and the E2~UBL complex.
Canonical E1 UBL and E2 specificity
In addition to their chemical roles in initiating UBL conjugation cascades, E1 enzymes also establish specificity, by matching a particular UBL with only cognate E2s. Rules for how this specificity is achieved are only beginning to emerge, but it is clear that specificity is achieved at multiple levels.
E1s are highly specific for their cognate UBLs 66, 84 . The best-understood example involves UBA1 and UBA3 distinguishing between the C-terminal tail residue Arg72 in ubiquitin and Ala72 in NEDD8 (ReFS 66, 67, 74, 84) . In both cases, residue 72 makes positive contacts with the E1 (ReFS 49,51,67) . However, most of the selectivity of UBA3 comes from a unique Arg that repels the Arg72 of ubiquitin 72 . The E1 and E2 selectivity for the ubiquitin, NEDD8, SuMo and ISG15 cascades seems to involve at least two non-covalent interaction surfaces. First, selectivity is dictated by interactions between the UFD of an E1 and the N-terminal sequence of an E2 catalytic domain. Swapping the UFD of UBA6 or UBA7 with that of UBA1 alters E2 specificity, and transplanting N-terminal sequences of UBCH8 (the E2 of ISG15) into UBCH7 (the E2 of ubiquitin; also known as UBE2L3) resulted in improved binding to UBA7, the E1 of ISG15, by roughly 20-fold 44, 78 . Pathway-specific E1-E2 interactions also impart selectivity. A unique N-terminal extension on UBC12 (the E2 of NEDD8) docks in a groove that is exclusive to UBA3 (ReFS 68, 70) . By contrast, relative to the smaller catalytic Cys domain from UBA3, UBA1 and UBA2 have unique insertions near the catalytic Cys that have been implicated in binding to their cognate E2s 51, 85, 86 . These distinctive interaction surfaces also select against offpathway mis-charging: these are key features that mask the vestigial ability of UBC12 to bind the ubiquitin E1 UBA1 (ReF. 87 ).
In vivo regulation of canonical E1s
Although the mechanisms that underlie the recognition of ubiquitin-like proteins and the specificity of transfer to E2s are beginning to be understood, far less is known about how E1s are regulated in vivo.
The E1 enzymes for ubiquitin. In the early 1980s, landmark studies identified temperature-sensitive mutations in mammalian UBA1. Cells with these mutations arrest the cell cycle at the G2-M phase transition and display dramatically decreased ubiquitin conjugation 88, 89 . RNA interference-mediated knockdown of UBA1 also diminished human cell proliferation 90 . Cells that contain temperature sensitive UBA1 variants have been used to test roles for ubiquitin in vivo, such as in the turnover of an unstable protein or in a specific pathway, for example, endocytosis or phagocytosis 91, 92 . 79, 96 . Reduced UBA1 activity in flies leads to tissue overgrowth, which raises the possibility that UBA1 is regulated during development and/ or that UBA1 has tumour-suppressive functions. uba-1 knockdown in C. elegans leads to enhanced aggregation of a polyglutamine-containing protein, which is consistent with the involvement of the ubiquitin system in removing misfolded and polyglutamine-containing proteins 97 . In addition, missense mutations in UBA1 are associated with spinal muscular atrophy, a motor neuron disorder that involves spinal motor neuron protein degradation through the ubiquitin system 98 . The use of RNA interference helped to distinguish the functions for the multiple ubiquitin E1s that are found in higher eukaryotes 44 . UBA1 knockdown virtually eliminates ubiquitin charging of two UBA1-specific E2s -cell division cycle regulatory protein 34 (CDC34) and CDC34B (also known as UBE2R2). By contrast, depletion of UBA6 essentially eliminates ubiquitin charging of USE1 but not CDC34 E2s 44 . UBA1 and UBA6 seem to have different catalytic efficiencies in vivo. Essentially all of the UBA1 molecules that are present in proliferating mammalian cells, as well as the tested UBA1 substrate E2s, CDC34 and CDC34B, are in their activated or charged forms at steady state 44 . This suggests that there is sufficient E1 activity to maintain fully charged pools of E2s, and that the interaction of charged E2s with E3s is rate-limiting for target ubiquitylation. Under similar conditions, UBA6 and its specific E2 USE1 are only ~50% activated or charged 44 . Are the E1 enzymes for ubiquitin regulated? Although to date UBA6 regulation remains uncharacterized, UBA1 has been found to be phosphorylated. Proposed roles of UBA1 phosphorylation include increasing nuclear import and/or retention 99 , and modulation of nucleotide excision repair during macrophage differentiation 100 . Furthermore, distinct isoforms of UBA1 display different subcellular localizations 101 , although the functions of different UBA1 modifications and isoforms remain poorly understood.
The E1 enzyme for ISG15. The expression of the ISG15 E1, UBA7, is induced by interferon-α and -β, which is consistent with the idea that the ISG15 pathway has a role in the antiviral response that is induced by interferon-α and interferon-β 41 . Further evidence for a role in the antiviral response comes from the finding that UBA7-dependent activation is prevented by the binding of the influenza protein NS1B to ISG15 (ReF. 41 ).
The SUMO E1 enzyme. SuMo E1 activity seems to be regulated at many levels. The UBA2 subunit of the heterodimeric SuMo E1 has a C-terminal nuclear localization sequence (NLS). NLS deletion from S. cerevisiae Uba2 results in nuclear to cytoplasmic relocalization and altered SuMo conjugation 102 . SAE1-SAE2 activity is also altered in the presence of reactive oxygen species: in the presence of H 2 O 2 , the catalytic Cys residues of uBA2 and the SuMo E2, uBC9, become covalently linked by a disulphide bond, thereby inhibiting sumoylation 103 . SuMo activation is also inhibited by the avian adenovirus chicken embryo lethal orphan (CELO) protein Gam1 (ReF. 104) . Gam1 possesses a suppressor of cytokine signalling (SOCS)-box motif, which allows assembly into an E3 that targets SAE1 for ubiquitin-mediated proteolysis 105 .
The NEDD8 E1 enzyme. An important role for NEDD8 activation was uncovered with the identification of a mammalian cell line that contains a temperature-sensitive mutation in APPBP1, which is a subunit of NAE1. At the non-permissive temperature at which NAE1 is inactive, there are defects in coupling of DNA synthesis and mitosis 106, 107 . Furthermore, the ultimate function of NAE1-UBA3 to transfer NEDD8 to its E2 UBC12 is also inhibited by reactive oxygen species that are induced by bacteria, which apparently inactivate the catalytic Cys of Ubc12 without promoting crosslinking to UBA3 (ReF. 108) .
Additional tools, including specific small-molecule inhibitors of various E1
, are under development and have the potential to greatly facilitate the functional analysis of the E1 enzymes in various processes.
Non-canonical E1 enzymes
Non-canonical E1s seem to initiate their UBL cascades through related but distinct mechanisms. The E1s UBA4 and ATG7 are conserved among all eukaryotes but have been best characterized in S. cerevisiae. These activate their respective uBL proteins: uRM1 and the two UBL proteins that are involved in autophagy (ATG8 and ATG12) 43, [52] [53] [54] . Like MoeB and ThiF, uBA4 and ATG7 both form homodimers (FIG. 3A) . Similarly, UBA5 has not been found to partner with another protein that has homology to MoeB and ThiF, which also suggests homodimerization (FIG. 3A) . Thus, as with MoeB and ThiF, these E1s might simultaneously bind two UBLs, one at each adenylation active site. The sequences of each of these E1 enzymes reflect unique features, probably for distinct functions downstream of UBL adenylation (see below).
UBA4 functions in sulphur transfer reactions.
Mutations in Uba4 and Urm1 in yeast lead to defects in invasive and pseudohyphal growth (in which yeast cells grow invasively into agar), in the response to oxidative stress, in the response to nutrient starvation, and in signalling through the target of rapamycin (ToR) pathway. yeast Uba4 was initially shown to promote Urm1 conjugation to at least one protein target, alkyl hydroperoxide reductase 1 (Ahp1), in a manner that requires the catalytic Cys of Uba4. This suggests parallels to traditional UBL conjugation cascades 42, 109 (FIGS 1,6). whereas Urm1 modification of Ahp1 has been linked to oxidative stress, cells that lack Uba4 or Urm1 display additional phenotypes that are not observed with Ahp1 deletion, suggesting additional roles for urm1. Moreover, no E2 has been identified to either form a thioester bond with Urm1 or to bind to Uba4, and it is not clear whether human uBA4 also promotes the conjugation of uRM1 to proteins.
Several recent findings reveal that yeast Uba4 and human UBA4 function in a manner that is more closely related to E. coli MoeB and ThiF than to canonical E1s. As with MoeB and ThiF activation of MoaD and ThiS,
Box 1 | E1 inhibitors
The development of specific inhibitors of E1 (or activating) enzymes, including cell permeable small-molecule inhibitors, is an important area of current research. Several E1 inhibitors have been reported, most of which target ubiquitinactivating enzyme 1 (UBA1). The first of these inhibitors, adenosylphosphoubiquitinol (APU), is a non-hydrolysable analogue of ubiquitin~adenylate 73 (the tilde (~) represents a high-energy bond) . Replacement of a ubiquitin carboxyl-terminal Gly76 oxygen with a methylene group prevents reactivity, rendering APU as a high affinity intermediate analogue that apparently occupies both the ubiquitin-and ATP-binding sites. The 35 nM inhibition constant (K i ) value of APU is substantially lower than Michaelis constant (K m ) values for ubiquitin and ATP. Small-molecule UBA1 inhibitors include a natural product, panepophenanthrin, which inhibits UBA1~ubiquitin thioester formation in vitro by an uncharacterized mechanism 117 , and a commercially available cell-permeable inhibitor, PYR41, which was identified in a high-throughput screening of an E1-E2-E3 cascade and might block the catalytic Cys of UBA1 (ReF. 118) .
NAE1-UBA3 (neuronal precursor cell-expressed developmentally downregulated protein 8 (NEDD8)-activating enzyme 1-ubiquitin-activating enzyme 3) can also be inhibited by multiple mechanisms. ATP-competitive inhibitors of NAE1-UBA3 are in development as anticancer therapeutics. A second mechanism for NAE1-UBA3 inhibition takes advantage of its unique interaction with the E2 of NEDD8, ubiquitin-like protein-conjugating enzyme 12 (UBC12): a synthetic peptide that corresponds to the 26-residue amino-extension of UBC12 (called UBC12N26) can competitively inhibit the binding of UBC12 to NAE1-UBA3 (ReF. 70) . Despite the poor K i (20 μM), its high specificity makes UBC12N26 a useful in vitro NAE1-UBA3 inhibitor, allowing the quenching of UBC12~NEDD8 charging to characterize downstream steps in the NEDD8 pathway using pulse-chase assays. 
Rhodanese homology domain
A domain that shares sequence and structural homology to rhodanese, a mitochondrial enzyme that catalyses Cys-mediated sulphur transfer reactions.
PP loop ATPase domain
A structural motif found in a family of conserved ATP-binding proteins that serve as tRNA-modifying enzymes and activate the tRNA through adenylation.
Elongator complex
An enzyme complex that replaces the hydrogen atom on position 5 of uridine at nucleotide 34 of tRNAs by a methoxycarbonylmethyl group.
respectively, Uba4 and UBA4-mediated thiocarboxylated uRM1 might serve as a sulphur donor in the thiolation pathways 110, 111 (FIG. 6) . First, Uba4 and UBA4 have a ~120-residue rhodanese homology domain (RHD) that is C-terminal to their adenylation domain. Rhodanese domain enzymes, which include some MoeB orthologues and ThiI, which is downstream of ThiF in the thiamin biosynthesis pathway, are thought to catalyse sulphur transfer. Second, Uba4 catalyses thiocarboxylation of human uRM1 in vitro 54,111 and uRM1 is thiocarboxylated in vivo 110 . Third, a downstream role for uRM1 as a sulphur carrier is implicated by the findings that both uRM1 and uba4 or uBA4 are required for uridine thiolation in certain tRNA molecules (tRNA Lys with anticodon sequence UUU, tRNA Gln (UUG) and tRNA Glu (UUC)) in yeast and mammalian cells 110, 111 . In yeast, these tRNA modifications also involve the interaction of Urm1 with multimeric ATP-binding protein complexes that are composed of Ncs6, Ncs2 and an uncharacterized open reading frame yor251c, presumably in a step of the cascade that is downstream of activation by the Uba4 E1 (FIG. 6) . In mammals, the analogous complex has recently been identified and is composed of the ATP-binding domaincontaining protein ATPBD3 (which has similarity to Ncs2), and a previously uncharacterized open reading frame (LOC348180) that has similarity to Ncs6 (ReF. 110) (FIG. 6) (P. Lee and J.w.H., unpublished observations).
Ncs6 and ATPBD3 each contain a PP loop ATPase domain, which is known to function in the adenylation of tRNAs. Ncs6 and its C. elegans orthologue TUT-1 were shown to bind directly to tRNAs 111 . Genetic data suggest that Ncs6 specifically binds to tRNAs that have been modified on their wobble uridine 34 moiety by a methoxycarbonylmethyl group in a reaction that is catalysed by the elongator complex. Indeed, mutations in this complex reduce the viability of yeast cells that also have deletions in the URM1 and URM4 genes 111 . Consistent with their involvement in this pathway, the deletion of UBA4 or URM1 in yeast or depletion of UBA4 or URM1 Figure 6 | The uBa4 pathway. Yeast ubiquitin-activating enzyme 4 (Uba4) and its mammalian homologue (MOCS3 in humans) function to promote both sulphur transfer reactions through ubiquitin-related modifier 1 (URM1) as well as the conjugation of URM1 to other proteins by an isopeptide bond. URM1 forms an adenylate intermediate by the adenylation domain of UBA4 or Uba4. A reactive Cys (residue 397) in the rhodanese homology domain (RHD) of Uba4 becomes persulphurated, probably through the action of nitrogen-fixing bacteria S-like protein 1 (Nfs1) in a reaction that requires Cys. Through a process that is poorly understood from a mechanistic perspective, the adenylate on URM1 is replaced by a sulphur from the persulphide on Cys397, forming URM1 thiocarboxylate. URM1 thiocarboxylate associates with the ATP-binding subunit of a heterodimeric enzyme complex that is required for conversion of 5-(methoxycarbonylmethyl)uridine in the anticodon of U-rich tRNAs to the 2-thiouridine-methoxycarbonylmethyl derivative. In yeast, this complex is composed of Ncs2, Ncs6 and a previously unstudied protein, Yor251c. The ATP that is associated with Ncs6 has been proposed to make an adenylate with uridine, as an intermediate for the trans-thiolation reaction. 2-Thiouridine-methoxycarbonylmethyl is crucial for the fidelity of translation. In a separate process, URM1 has been proposed to be conjugated to alkyl hydroperoxide reductase 1 (Ahp1) in yeast, although the molecular intermediates in this process have not been defined.
Thiouridinylation
An enzymatic process in which the 2′ oxygen of uridine in the anticodon of a tRNA is replaced by sulphur.
in mammalian cells by RNA interference blocks uridine thiolation in vivo 110, 111 . Moreover, a reactive analogue of uRM1 (uRM1-vinyl-methylester) can be directly crosslinked to ATPBD3, suggesting that this subunit serves to bind both the tRNA and the uRM1 sulphur carrier 110 . Many questions remain to be answered, including: how does uRM1 lead to tRNA thiouridinylation? Is uRM1-thiocarboxylate the direct sulphur donor for tRNA, or is there a sulphur transfer pathway that involves additional enzymes? Does uRM1 carry sulphur for other pathways? And how might the dual functions of uRM1 as both a protein modifier (for proteins such as Ahp1) and a sulphur carrier be established? Can Uba4 or uBA4 transfer uRM1 to target proteins in a manner that is independent of an E2 intermediate? Finally, depletion of uRM1 in mammalian cells leads to defects in cytokinesis 110 . Thus, what role does uRM1 have in cell cycle control? ATG7 regulates autophagy. ATG7 functions at the apex of a signalling system that is required for autophagy, the process whereby the cell directs the degradation of cytoplasmic components in response to reduced nutrients in the environment. Despite its essential role in autophagy, many aspects of the function of ATG7 remain poorly understood. First, how does ATG7 recognize its two UBL substrates (ATG8 and ATG12), which are rather distantly related to one another (the yeast Atg8 and Atg12 share only 18% amino acid sequence identity) (FIG. 1c) ? Second, how does ATG7 mediate specific ATG8 charging of its dedicated E2 enzyme (ATG3), and ATG12 charging of its dedicated E2 enzyme (ATG10)? Third, how does ATG7 specifically recognize these two E2s? Fourth, does ATG7 also participate in ATG3-mediated transfer of ATG8 to its target, the lipid phosphatidylethanolamine, or ATG10-mediated transfer of ATG12 to its protein target, ATG5? Finally, mammals have a greatly expanded repertoire of ATG8 orthologues, with seven genes (FIG. 1c) . Although it is presumed that each of these is charged through the same pathway, whether these proteins have distinct functions remains unknown.
It is likely that some of these unique ATG7-mediated functions are carried out by the ~300 N-terminal and ~50 C-terminal residues that flank the ThiF-like adenylation domain. These ATG7-specific sequences lack detectable homology to suggest possible functions 47, 52, 114 (FIG . 3A) . Nonetheless, it is likely that, as with other E1 enzymes, these sequences beyond the adenylation domain bind the autophagy-specific E2s and promote UBL transfer. It seems that ATG3, the E2 for ATG8, binds to ATG7 in a unique way through an ~80 residue flexible region that is not shared with other E2s, including ATG10 (ReF. 115 ).
UBA5, a poorly understood non-canonical E1. UBA5, the E1 of uFM1, is found in multicellular organisms but not in yeast, and is perhaps the least-characterized E1 (ReF. 43) . The sequence of UBA5 suggests that the catalytic Cys is located in a loop, rather than in a discrete domain. The C-terminal domain of UBA5 is predicted to adopt a ubiquitin fold, as in canonical E1 UFDs, and bind to UFC1, the E2 of uFM1 (FIG. 1c) . This is analogous to that seen in the crystal structure of the UFD bound to the E2 in the NEDD8 pathway 116 . Future studies will be required to understand whether UBA5 functions as a homodimer, whether UBA5 is a relatively minimal version of a canonical E1, whether it can simultaneously transfer two UBL molecules to associated E2s or whether, like canonical E1s, it has evolved an asymmetric mechanism for initiating uFM1 activation. Moreover, the targets of uFM1 will need to be identified to begin to reveal biological roles for the uFM1-uBA5-uFC1 pathway.
Future directions
Our understanding of the important roles of the E1 enzymes has increased dramatically since the discovery of UBA1 in the early 1980s. Nevertheless, there is still much to be discovered. The detailed mechanism of UBL transfer to the Cys residue of an E1 enzyme and the subsequent transfer to E2 are still poorly understood. Furthermore, our knowledge of the conformational changes that are associated with these reactions is also lacking. Additionally, it is unclear why the number of E2s that work with UBA1 has been so dramatically expanded relative to the other cascades, which use a limited repertoire of E2s. In principle, this could reflect the wider array of ubiquitin targets, but it also indicates the special nature of UBA1 as a master activator of most E2s.
Further questions concern why particular UBL classes have expanded into multiple members. As examples, the distinct functions of the three SuMo and seven ATG8 family members in humans remain incompletely understood (FIG. 1) , as do any differences in their mechanisms of activation. Finally, E1 enzymes are unique in the UBL conjugating pathway in that they are the only components that use ATP. This property is being exploited to develop selective inhibitors. The potential for the use of such inhibitors in therapy is high, given the links that are seen between the components of UBL cascades and human disease.
Note added in proof A recent paper 121 describes the identification of a selective small molecule inhibitor of NAE1-UBA3 called MLN4924, the application of which to cells in culture inhibits NEDD8 conjugation and leads to stabilization of cullin targets, uncontrolled DNA synthesis, induction of the DNA damage pathway and cell death through apoptosis. MLN4924 reduces the proliferation of transformed cells in xenografts in mice, suggesting the possible application of such NAE1-UBA3 inhibitors in the treatment of cancer. An additional paper 122 describes the expansion of E2 conjugating enzymes that function with NAE1-UBA3 to neddylate cullins. UBE2F, a relative of UBC12, is charged with NEDD8 by NAE1-UBA3 but functions specifically to transfer NEDD8 to CUL5-RBX2 complexes, whereas UBC12 functions to neddylate other cullins that are associated with RBX1.
